Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
18,568
Price
$0.63
Total Value
$11.70K
Shares Held After
2,472,297
% of Holdings
0.7%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
885
Price
$63.16
Total Value
$55.90K
Shares Held After
50,440
% of Holdings
1.7%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
2,062
Price
$44.93
Total Value
$92.65K
Shares Held After
6,000
% of Holdings
25.6%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
37,938
Price
$44.40
Total Value
$1.68M
Shares Held After
8,062
% of Holdings
82.5%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
1,108
Price
$29.75
Total Value
$32.97K
Shares Held After
205,084
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
3,144
Price
$29.08
Total Value
$91.43K
Shares Held After
206,192
% of Holdings
1.5%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
8,748
Price
$28.17
Total Value
$246.40K
Shares Held After
209,336
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
CAUSEY CHRISTOPHER — Director
Shares
1,000
Price
$500.01
Total Value
$500.01K
Shares Held After
4,190
% of Holdings
19.3%
LeonaBio, Inc. (LONA)
Worthington Mark — General Counsel and CCO
Shares
876
Price
$6.88
Total Value
$6.03K
Shares Held After
13,978
% of Holdings
5.9%
LeonaBio, Inc. (LONA)
CHURCH KEVIN — CHIEF SCIENTIFIC OFFICER
Shares
876
Price
$6.88
Total Value
$6.03K
Shares Held After
20,681
% of Holdings
4.1%
LeonaBio, Inc. (LONA)
Renninger Robert — Chief Financial Officer
Shares
297
Price
$6.88
Total Value
$2.04K
Shares Held After
12,857
% of Holdings
2.3%
LeonaBio, Inc. (LONA)
Litton Mark James — Director
Shares
2,586
Price
$6.88
Total Value
$17.79K
Shares Held After
40,828
% of Holdings
6.0%
LeonaBio, Inc. (LONA)
San Martin Javier — CHIEF MEDICAL OFFICER
Shares
1,644
Price
$6.88
Total Value
$11.31K
Shares Held After
10,189
% of Holdings
13.9%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
1,157
Price
$79.27
Total Value
$91.72K
Shares Held After
37,793
% of Holdings
3.0%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
4,993
Price
$78.62
Total Value
$392.57K
Shares Held After
38,950
% of Holdings
11.4%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
350
Price
$77.67
Total Value
$27.18K
Shares Held After
43,943
% of Holdings
0.8%
Viking Therapeutics, Inc. (VKTX)
FOEHR MATTHEW W — Director
Shares
16,000
Price
$35.11
Total Value
$561.69K
Shares Held After
132,036
% of Holdings
10.8%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Anzalone Christopher Richard — Director
Shares
5,771
Price
$66.39
Total Value
$383.14K
Shares Held After
3,792,739
% of Holdings
0.2%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
200
Price
$177.78
Total Value
$35.56K
Shares Held After
41,754
% of Holdings
0.5%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
9,125
Price
$177.17
Total Value
$1.62M
Shares Held After
41,954
% of Holdings
17.9%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
12,832
Price
$176.08
Total Value
$2.26M
Shares Held After
51,079
% of Holdings
20.1%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
34,103
Price
$175.17
Total Value
$5.97M
Shares Held After
63,911
% of Holdings
34.8%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
31,030
Price
$174.28
Total Value
$5.41M
Shares Held After
98,014
% of Holdings
24.0%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
893
Price
$82.93
Total Value
$74.06K
Shares Held After
23,393
% of Holdings
3.7%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
835
Price
$81.90
Total Value
$68.39K
Shares Held After
24,286
% of Holdings
3.3%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
8,122
Price
$80.71
Total Value
$655.53K
Shares Held After
25,121
% of Holdings
24.4%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
3,750
Price
$38.42
Total Value
$144.06K
Shares Held After
39,760
% of Holdings
8.6%
BioAge Labs, Inc. (BIOA)
RUBIN PAUL D — Chief Medical Officer
Shares
7,433
Price
$12.85
Total Value
$95.49K
Shares Held After
0
% of Holdings
100.0%
Damora Therapeutics, Inc. (DMRA)
Firmani Lori — Chief Financial Officer
Shares
135
Price
$21.41
Total Value
$2.89K
Shares Held After
931
% of Holdings
12.7%
Damora Therapeutics, Inc. (DMRA)
Winslow Garrett — General Counsel
Shares
255
Price
$21.38
Total Value
$5.45K
Shares Held After
1,854
% of Holdings
12.1%
Damora Therapeutics, Inc. (DMRA)
Schambye Hans T. — Director
Shares
700
Price
$21.38
Total Value
$14.97K
Shares Held After
4,682
% of Holdings
13.0%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
2,595
Price
$39.57
Total Value
$102.68K
Shares Held After
12,965
% of Holdings
16.7%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
2,405
Price
$38.70
Total Value
$93.07K
Shares Held After
15,560
% of Holdings
13.4%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
4,432
Price
$40.43
Total Value
$179.19K
Shares Held After
0
% of Holdings
100.0%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
13,055
Price
$4.20
Total Value
$54.79K
Shares Held After
46,945
% of Holdings
21.8%
GALECTIN THERAPEUTICS INC (GALT)
CALLICUTT JACK W — Chief Financial Officer
Shares
13,914
Price
$4.20
Total Value
$58.39K
Shares Held After
53,700
% of Holdings
20.6%
GALECTIN THERAPEUTICS INC (GALT)
LEWIS JOEL — Director
Shares
18,571
Price
$4.20
Total Value
$77.94K
Shares Held After
898,021
% of Holdings
2.0%
PTC THERAPEUTICS, INC. (PTCT)
STEELE GLENN JR MD PHD — Director
Shares
12,000
Price
$76.35
Total Value
$916.20K
Shares Held After
18,500
% of Holdings
39.3%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
18,338
Price
$79.27
Total Value
$1.45M
Shares Held After
30,453
% of Holdings
37.6%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
5,125
Price
$78.57
Total Value
$402.67K
Shares Held After
30,453
% of Holdings
14.4%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
70,037
Price
$35.87
Total Value
$2.51M
Shares Held After
69,188
% of Holdings
50.3%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
46
Price
$192.40
Total Value
$8.85K
Shares Held After
43,654
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
207
Price
$190.27
Total Value
$39.39K
Shares Held After
43,700
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
102
Price
$188.96
Total Value
$19.27K
Shares Held After
43,907
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
91
Price
$187.95
Total Value
$17.10K
Shares Held After
44,009
% of Holdings
0.2%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
3,125
Price
$16.08
Total Value
$50.25K
Shares Held After
315,978
% of Holdings
1.0%
Bicycle Therapeutics plc (BCYC)
Lee Kevin — Director
Shares
10,325
Price
$6.80
Total Value
$70.21K
Shares Held After
629,985
% of Holdings
1.6%
Bicycle Therapeutics plc (BCYC)
Young Alethia — Chief Financial Officer
Shares
3,289
Price
$6.80
Total Value
$22.37K
Shares Held After
91,415
% of Holdings
3.5%
Bicycle Therapeutics plc (BCYC)
Milnes Alistair — CHIEF OPERATING OFFICER
Shares
3,244
Price
$6.80
Total Value
$22.06K
Shares Held After
140,133
% of Holdings
2.3%
Bicycle Therapeutics plc (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Shares
2,827
Price
$6.80
Total Value
$19.22K
Shares Held After
100,275
% of Holdings
2.7%
Showing 1101–1150 of 1179 transactions (page 23 of 24)